MX1 and neoplasm: Meanwhile, Abx treatment inhibited the expression of type I interferon (IFNβ), and ISGs (MX1, ISG15, and IFIT1) in small intestine and tumor tissues, validating its regulation on IRF3 activation (Supplementary Fig. S6h).